ConquerX Company

ConquerX is a biotechnology company that provides innovative molecular profiling solutions to clinical trials in precision medicine. The company's flagship product, the EbeGen, is an electro-chemical biosensor capable of detecting multiple molecular targets such as DNAs, RNAs, mirRNAs at the same time, without the need for sequencing and qPCR and at 10-time more cost effective compared to current technologies.

Industry: BioTech
Technology: Other
Investors Number: 2
Headquarters: Boston, Massachusetts, United States
Employee Number: 1-10
Investor Type: For Profit
Total Funding: 81868
Founded Date: 2016-01-01
Last Funding Type: Grant